Hyperlipidemia: Difference between revisions

Jump to navigation Jump to search
Line 24: Line 24:


==Treatment==
==Treatment==
'''NCEP recommendations for children and adolescents with high-risk hyperlipidemia'''
===NCEP recommendations for children and adolescents with high-risk hyperlipidemia===


[[Hyperlipidemia NCEP recommendations for drug therapy of high-risk hyperlipidemia in children and adolescents | Recommendations for drug therapy]] | [[Hyperlipidemia statins in children and adolescents with hyperlipidemia | Statins]] | [[Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents | Adjuvant therapies]]
[[Hyperlipidemia NCEP recommendations for drug therapy of high-risk hyperlipidemia in children and adolescents | Recommendations for drug therapy]] | [[Hyperlipidemia statins in children and adolescents with hyperlipidemia | Statins]] | [[Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents | Adjuvant therapies]]


[[Hypertriglyceridemia medical therapy | Pharmacotherapy]]
===[[Hypertriglyceridemia medical therapy | Pharmacotherapy]]===


[[Statins]] | [[Niacin]] | [[Fibrate]] | [[Omega-3 fatty acids]]
[[Statins]] | [[Niacin]] | [[Fibrate]] | [[Omega-3 fatty acids]]

Revision as of 14:24, 20 November 2011